Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

485
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
485
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

659
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
659
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

360
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
360
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

427
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
427
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

511
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
511
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

539
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
539

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Framework for Building an Inclusive Quality Program in a Pediatric Heart Center.

Pediatric quality & safety·2026
Same author

Single Ventricle Infant Deaths Without Transplant Referral: Room for Improvement?

Pediatric cardiology·2026
Same author

Canadian Cardiovascular Society/Canadian Pediatric Cardiology Association Focused Guidelines on Acute Heart Failure in Children.

The Canadian journal of cardiology·2026
Same author

Evaluation and Management of the Child With Acute Decompensated Heart Failure: A Scientific Statement From the American Heart Association.

Circulation·2026
Same author

Update on Education for Families and Patients With Pediatric Heart Disease: A Focus on Technological Advancements, Procedures, and Transitions of Care: A Scientific Statement From the American Heart Association.

Journal of the American Heart Association·2026
Same author

A Large Cohort Study to Identify Risk Factors of Acute Kidney Injury in Pediatric Patients Undergoing Intravenous Vancomycin Therapy.

Pharmacotherapy·2025

Related Experiment Video

Updated: Mar 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.3K

Readmissions for Heart Failure in Children.

Brady S Moffett1, Timothy J Humlicek1, Joseph W Rossano2

  • 1Department of Pharmacy, Texas Children's Hospital, Houston, TX; Department of Pediatrics, Section of Pediatric Cardiology, Baylor College of Medicine, Houston, TX.

The Journal of Pediatrics
|July 4, 2016
PubMed
Summary

Pediatric heart failure patients with cardiomyopathy experience frequent 30-day hospital readmissions. Discharge medications did not significantly impact these readmission rates, highlighting a need for further research into effective interventions for pediatric heart failure management.

Keywords:
ACE inhibitorsbeta-blockersheart failurepediatricreadmission

More Related Videos

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

130
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

750

Related Experiment Videos

Last Updated: Mar 18, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.3K
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

130
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

750

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Pharmacotherapy Efficacy

Background:

  • Pediatric heart failure (HF) and cardiomyopathy (CMP) are serious conditions requiring intensive management.
  • Readmissions after initial hospitalization pose a significant burden on patients, families, and healthcare systems.
  • Understanding readmission drivers is crucial for improving care transitions in pediatric HF.

Purpose of the Study:

  • To determine the frequency of 30-day hospital readmissions for heart failure in children diagnosed with cardiomyopathy.
  • To evaluate the impact of discharge pharmacotherapy on the rate of 30-day readmissions for heart failure in this pediatric population.

Main Methods:

  • Utilized the Pediatric Health Information System Database (2004-2013) for patients aged 18 years or younger with HF or CMP codes.
  • Excluded patients with congenital heart disease, in-hospital mortality, or prior cardiac surgery.
  • Employed mixed-effects multivariable logistic regression to identify factors associated with 30-day readmission.

Main Results:

  • A total of 2386 pediatric patients met the inclusion criteria.
  • The 30-day readmission rate for heart failure was 12.9%.
  • Discharge use of milrinone or beta-blockers, and higher institutional HF patient volume were linked to increased readmission odds; mechanical ventilation during initial admission was associated with decreased odds.

Conclusions:

  • Pediatric patients with cardiomyopathy and heart failure exhibit a high incidence of 30-day heart failure-related readmissions.
  • Current outpatient pharmacotherapy regimens at discharge do not appear to significantly influence readmission rates.
  • Further investigation is warranted to identify effective strategies for reducing readmissions in this vulnerable pediatric population.